RespireRx Pharmaceuticals Inc (fka RSPI)

[neuroinv]

Gfp:

As I posted last week, the deals I have seen have been priced at 'average of closing price for five days'--so if a financing was done today, it would be around 30 cents. They have also been pretty 'vanilla', comprising those shares plus warrants.

I wasn't particularly predicting a certain number of shares, just noting the stakes involved in their pricing. Your point about the authorized share limit is very pertinent.

While the share price is appalling, the idea of raising 'only' $5-6 million is not in itself abhorrent. That plus a modest RD deal would give them enough runway to get a SA deal IF those data are positive.

NeuroInvestment